Natco Pharma Ltd.: Share Price, Stock Analysis, Annual Report | Value Research Get Natco Pharma Ltd.'s stock analysis, price valuation, corporate actions, and financials from India's independent mutual fund research house.
info-circle
NATCO PHARM

Click to see a quick summary and important updates about this stock!Dismiss

Natco Pharma Ltd.

BSE: 524816, NSE: NATCOPHARM

  • Market Capitalisation info

    ₹10,935 Cr


  • 12 Month Earnings info

    ₹415 Cr

  • Price to Earnings info

    26.32

₹599.50

As on 28-Sep-2022 11:14 IST

up-down-arrow2.600.44%

  • Prev Close info

    596.90

  • Day's Openinfo

    592.60

  • Today's Highinfo

    602.00

  • Today's Lowinfo

    592.45

  • Today's Volumeinfo

    60,342

Please wait...

Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Natco Pharma
-33.73 -3.98 -6.18 -31.65 -0.07 -4.87 23.12
S&P BSE Healthcare
-12.55 0.75 5.49 -11.54 21.77 11.48 11.91
S&P BSE Mid Cap
-1.54 -2.12 11.80 -2.42 19.89 10.11 14.17
As on 28-Sep-2022
2021
2020
2019
2018
2017
2016
2015
Natco Pharma
-6.48 55.58 -14.53 -31.05 65.91 0.56 90.60
S&P BSE Mid Cap
39.18 19.87 -3.05 -13.31 48.13 7.97 7.43
S&P BSE Healthcare
20.87 61.45 -3.55 -5.89 0.49 -12.88 15.06

Valuation

Stock
Peer Median
Please wait...

Growth & Efficiency

Stock
Peer Median
Please wait...

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        News & Analysis

        Other Details

        Incorporated

        1981

        Chairman

        GS Murthy

        Managing Director

        V C Nannapaneni

        Group

        Natco

        Headquarters

        Hyderabad, Telangana
        Edit edit
        Please wait...
        Please wait...
        Please wait...
        Please wait...

        Key Facts

        • Market cap info

          ₹10,935.17 Cr

        • Revenue (TTM) info

          ₹2,419.10 Cr

        • Earnings (TTM) info

          ₹415.40 Cr

        • Cash info

          ₹409.80 Cr

        • Total Debt info

          ₹404.00 Cr

        • Promoters' ownership info

          48.80%

        • Liquidity info

          High

        • 52 Week range info

          ₹592.45 - 944.00

        • Face value info

          ₹2.00

        • Shares outstanding info

          18,25,57,165

        • 10 Years Aggregate:

          CFO: ₹2,650.90 Cr

          EBITDA: ₹4,671.74 Cr

          Net Profit: ₹3,343.06 Cr

        About The Company

        • Business

          Manufacture of pharmaceuticals, medicinal chemical and botanical products

        • Incorporated

          1981

        • Chairman

          GS Murthy

        • Managing Director

          V C Nannapaneni

        • Group

          Natco

        • Listing info

          BSE: 524816, NSE: NATCOPHARM

        • Country

          India

        • Headquarters info

          Hyderabad, Telangana

        • Website info

          www.natcopharma.co.in